Subacute idiopathic pericarditis with a large pericardial effusion in a young adult seven months post COVID-19 (SARS-Cov-2) infection
1 DO PGY-3 Internal Medicine Resident Sunrise Health GME Consortium, Mountain View Hospital2880 N Tenaya Way, 2nd Floor Las Vegas, NV, 89128.
2 Associate Program Director in Internal Medicine Residency Program Sunrise Health GME Consortium, Mountain View Hospital 2880 N Tenaya Way, 2nd Floor Las Vegas, NV, 89128
Case Study
World Journal of Advanced Research and Reviews, 2021, 10(01), 340-342
Article DOI: 10.30574/wjarr.2021.10.1.0187
Publication history:
Received on 21 March 2021; revised on 26 April 2021; accepted on 28 April 2021
Abstract:
The number of COVID-19 (SARS-Cov-2) cases has risen substantially throughout the world, and consequently we are finding there are several extrapulmonary manifestations associated with this disease. Viral pericarditis and pericardial effusion have been reported several times in COVID-19 patients, however the majority of these cases occurred during active infection or within a relatively short time frame afterwards. The following case is a young female with only a past medical history of COVID-19 pneumonia, seven months prior, presenting with abdominal pain and progressively worsening dyspnea. She was subsequently found to have a large pericardial effusion without tamponade, but requiring a pericardial window. Gross pathology showed fibrinous pericarditis. It is suspected her symptoms and pericardial effusion resulted from a subacute idiopathic pericarditis likely as post-viral complication of COVID-19.
Keywords:
COVID-19; Subacute pericarditis; Pericardial effusion; Pericardial window
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0